This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Power Players From TechCrunch Disrupt, Ep 2
Phoebe Gates and Sophia Kianni launch fashion tech startup Phia, Coinbase talks M&A under pro-crypto administration, and Clyx introduces AI event finder
Go Fund Yourself: The Future is Electric & Delicious
VoltFMP electrifies the future with “Digital Electricity” power networks. Plus, Embarc Wines invites viewers on a self-guided San Francisco wine bar pouring.
Can A 50-Year Mortgage Fix The Housing Market—or Make It Worse?
Home prices far outpacing incomes, low inventory, and higher living costs are reshaping the market. WSJ’s Veronica Dagher breaks down the challenges ahead.
This AI Security Device Uses Pepper Gel to Stop Active Threats in Schools
Discover how ShotHawk's AI-powered security unit can detect and disarm active shooters in schools and public spaces in seconds
As Commercial Capacity Shrinks, Is Private Aviation Becoming a Necessity?
As commercial options tighten, more travelers are turning to private aviation. Wheels Up CEO George Mattson breaks down capacity and demand challenges.
Goodfin CEO Anna Joo Fee On AI Trust, Transparency, And The Future Of Finance
AI, private markets, and alternative assets are converging fast. Goodfin’s CEO explains how new tech is opening doors for retail investors.
